Skip to content

Dynamic EchoCardiographic Optimisation REsponse Study

Dynamic EchoCardiographic Optimisation REsponse Study (Studio Sulla Risposta All'Ottimizzazione Dinamica Ecocardiografica)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05473481
Acronym
DECORE
Enrollment
73
Registered
2022-07-26
Start date
2022-07-01
Completion date
2025-03-31
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The aim of this study is to evaluate the effects of heart rate optimization and guided A-V and V-V delay from color Doppler echocardiography, in subjects affected by heart failure with reduced ejection fraction and CRT-D device wearers who did not respond to device implantation in clinical, electrophysiological, and other terms.

Interventions

None listed

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patient must be 18 to 85 years of age inclusive, at the time of signing the informed consent form; 2. Heart failure with ventricular ejection fraction left \<45%; 3. Presence of CRT-D devices in a non-responder patient for cardiac resynchronization 4. NYHA \>II; 5. Resting heart rate \<65 beats per minute; 6. Biventricular pacing \>97%.

Exclusion criteria

1. Age \<18 and \>85 years; 2. Insufficient functional capacity to complete the tests required by the research protocol; 3. Permanent Atrial Fibrillation

Design outcomes

Primary

MeasureTime frameDescription
Change in the number of acute heart failure episodesBaseline to 12 months post dischargeNumber of worsening HF episodes requiring hospitalization
Change in left ventricular ejection fraction (LVEF)Baseline to 12 months post dischargeAn echocardiogram will be performed at specific study visits and LEVF will be measured
Echocardiofic changes of diastolic left ventricular functionBaseline to 12 months post dischargeAn echocardiogram will be performed at specific study visits and LVESV and LVEDV will be

Secondary

MeasureTime frameDescription
Change in Kansas City Cardiomyopathy Questionnaire (KCCQ)Baseline to 12 months post dischargeThis is a disease-specific health status instrument composed of 23 items that quantify the domains of physical limitation, symptoms, self-efficacy, social limitation, and quality of life limitation due to HF. Scores range from 0 to 100. For the KCCQ overall summary score, a small but clinically meaningful change is ≥ 5 points.
Change in NYHA classBaseline to 12 months post dischargeMeasures of New York Heart Association functional class stratified I to IV at baseline and at each scheduled time.

Countries

Italy

Contacts

Primary ContactMassimo Saviano, MD
massimo.saviano@policlinico.mi.it+390255033579

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026